Assyro AI

Orange Book product · Brand (NDA)

KYXATA

CARBOPLATIN

Brand (NDA)NDA 219921DISCN AVYXA HOLDINGS

At a glance

Aug 08, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 08, 2025

    11 mo ago

  2. Today

  3. Patent 12427104 expires

    Listed drug product patent expiration.

    Apr 01, 2045

    in 19 yr 1 mo

Pharmaceutical detail

Active ingredient

CARBOPLATIN

Strength

20MG/2ML (10MG/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 219921

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12427104Apr 01, 2045in 19 yr 1 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.